The last paragraph of this article has been corrected to note that the $150 million in funding is in support of the Strategic Research Initiative.

NEW YORK (GenomeWeb) – Researchers at Indiana University have announced the launch of a new study in which they will use targeted sequencing provided by testing firm Paradigm to try to direct personalized treatment strategies for women with triple-negative breast cancer (TNBC) in the hopes of extending their lives.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.